Expanded Access Program With Nivolumab to Treat Melanoma
The purpose of this program is to provide treatment with nivolumab to subjects with Stage III or Stage IV advanced melanoma.
Stage III (Unresectable) or Stage IV Advanced Melanoma
DRUG: Nivolumab
The purpose of this program is to provide treatment with nivolumab to subjects with Stage III or Stage IV advanced melanoma.